Your browser is no longer supported. Please, upgrade your browser.
Settings
TXG [NASD]
10x Genomics, Inc.
Index- P/E- EPS (ttm)-4.72 Insider Own1.60% Shs Outstand109.87M Perf Week-5.82%
Market Cap17.38B Forward P/E- EPS next Y-0.18 Insider Trans-24.34% Shs Float86.20M Perf Month-4.80%
Income-504.00M PEG- EPS next Q-0.20 Inst Own88.70% Short Float4.02% Perf Quarter-24.34%
Sales405.70M P/S42.83 EPS this Y-571.20% Inst Trans6.40% Short Ratio5.82 Perf Half Y-5.66%
Book/sh7.14 P/B21.34 EPS next Y64.00% ROA-51.60% Target Price203.67 Perf Year22.61%
Cash/sh5.45 P/C27.94 EPS next 5Y- ROE-65.00% 52W Range122.26 - 208.99 Perf YTD7.61%
Dividend- P/FCF- EPS past 5Y- ROI-73.60% 52W High-29.61% Beta-
Dividend %- Quick Ratio6.30 Sales past 5Y- Gross Margin86.40% 52W Low20.32% ATR7.27
Employees1053 Current Ratio6.70 Sales Q/Q169.90% Oper. Margin- RSI (14)32.15 Volatility4.01% 4.38%
OptionableYes Debt/Eq0.00 EPS Q/Q75.20% Profit Margin- Rel Volume0.66 Prev Close152.38
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout- Avg Volume596.05K Price147.10
Recom1.60 SMA20-13.28% SMA50-13.84% SMA200-15.24% Volume245,263 Change-3.46%
Sep-14-21Downgrade BofA Securities Buy → Neutral $180
Mar-15-21Initiated William Blair Outperform
Dec-02-20Initiated Goldman Neutral $150
Sep-09-20Initiated Morgan Stanley Overweight $135
Jul-10-20Initiated Stifel Buy $105
Mar-05-20Initiated Guggenheim Buy $96
Jan-07-20Initiated Citigroup Buy $100
Oct-07-19Initiated JP Morgan Overweight $55
Oct-07-19Initiated Cowen Outperform $55
Oct-07-19Initiated BofA/Merrill Buy $62
Sep-24-19Initiated Evercore ISI Outperform $70
Sep-27-21 11:45AM  
Sep-08-21 01:34PM  
Aug-31-21 04:05PM  
Aug-06-21 08:00AM  
Aug-04-21 06:05PM  
04:05PM  
Aug-03-21 08:44AM  
Jul-28-21 03:03PM  
Jul-27-21 06:30AM  
Jul-20-21 09:11AM  
Jul-14-21 08:00AM  
Jul-07-21 04:03PM  
Jun-25-21 05:35AM  
Jun-22-21 05:11AM  
Jun-10-21 08:00AM  
May-29-21 01:06PM  
May-28-21 02:18PM  
05:21AM  
May-25-21 04:47PM  
May-24-21 08:00AM  
May-20-21 06:50AM  
May-13-21 04:21PM  
May-05-21 09:05PM  
05:10PM  
04:03PM  
Apr-29-21 04:05PM  
Apr-28-21 05:32PM  
12:33PM  
Apr-24-21 06:35AM  
Apr-23-21 06:59AM  
Apr-19-21 08:21AM  
Apr-17-21 08:00AM  
06:01AM  
Apr-12-21 04:44PM  
Apr-10-21 08:00AM  
Apr-06-21 10:02AM  
08:02AM  
06:04AM  
Apr-05-21 10:02AM  
07:05AM  
06:04AM  
Apr-04-21 09:12PM  
11:01AM  
07:03AM  
Apr-03-21 02:01PM  
09:01AM  
06:04AM  
Apr-02-21 09:03AM  
06:03AM  
Apr-01-21 08:30AM  
Mar-29-21 10:01AM  
Mar-25-21 10:46AM  
Mar-09-21 08:30AM  
Feb-25-21 08:05AM  
Feb-24-21 04:05PM  
Feb-22-21 07:19AM  
Feb-18-21 06:00AM  
Feb-17-21 04:56PM  
04:03PM  
Feb-14-21 08:10AM  
Feb-10-21 12:31PM  
Jan-28-21 04:10PM  
Jan-07-21 10:26AM  
Dec-23-20 04:03PM  
Dec-22-20 05:54AM  
Dec-21-20 12:36PM  
Dec-18-20 04:24PM  
Dec-12-20 08:09AM  
Dec-08-20 08:53AM  
Dec-05-20 08:01AM  
Dec-02-20 09:52AM  
Nov-10-20 05:35PM  
04:05PM  
Nov-04-20 06:00PM  
Nov-03-20 12:31PM  
Oct-21-20 01:11PM  
Oct-13-20 04:15PM  
11:32AM  
Oct-05-20 04:15PM  
Sep-15-20 04:25PM  
09:21AM  
08:00AM  
Sep-14-20 10:09AM  
Sep-10-20 11:16PM  
Sep-08-20 04:20PM  
Sep-01-20 04:03PM  
Aug-18-20 02:04PM  
Aug-11-20 04:05PM  
Aug-06-20 05:00PM  
Jul-28-20 11:12AM  
Jul-14-20 09:00AM  
Jun-22-20 10:37AM  
Jun-17-20 09:00AM  
Jun-16-20 08:39AM  
May-20-20 09:00AM  
May-19-20 09:15AM  
09:00AM  
May-12-20 05:31AM  
May-11-20 04:03PM  
May-05-20 04:03PM  
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kosaraju SridharDirectorSep 23Sale159.041,500238,5627,500Sep 24 06:37 PM
STUELPNAGEL JOHN RDirectorSep 16Sale156.335,000781,668371,616Sep 20 07:26 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerSep 13Option Exercise1.1617,00019,72060,336Sep 15 06:09 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerSep 13Sale174.4917,0002,966,31243,336Sep 15 06:09 PM
Saxonov SergeChief Executive OfficerSep 07Option Exercise9.2415,000138,654913,468Sep 09 05:28 PM
Saxonov SergeChief Executive OfficerSep 07Sale188.4215,0002,826,232898,468Sep 09 05:28 PM
Hindson Benjamin J.See RemarksSep 01Option Exercise5.0441,666209,99788,783Sep 03 07:52 PM
McAnear Justin J.Chief Financial OfficerSep 01Option Exercise5.0410,00050,40049,100Sep 03 07:54 PM
Hindson Benjamin J.See RemarksSep 01Sale177.5041,6667,395,88747,117Sep 03 07:52 PM
STUELPNAGEL JOHN RDirectorSep 01Sale177.485,000887,411376,616Sep 03 07:55 PM
McAnear Justin J.Chief Financial OfficerSep 01Sale177.4910,0001,774,92739,100Sep 03 07:54 PM
Kosaraju SridharDirectorAug 23Sale162.061,500243,0889,000Aug 25 08:39 PM
Saxonov SergeChief Executive OfficerAug 23Sale161.85742120,091903,326Aug 25 08:38 PM
McAnear Justin J.Chief Financial OfficerAug 23Sale161.8527043,69939,100Aug 25 08:37 PM
Hindson Benjamin J.See RemarksAug 23Sale161.8533754,54347,117Aug 25 08:37 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerAug 23Sale161.8527043,69943,336Aug 25 08:36 PM
STUELPNAGEL JOHN RDirectorAug 16Sale159.565,000797,824381,616Aug 18 06:56 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerAug 12Option Exercise1.1617,00019,72060,606Aug 16 04:06 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerAug 12Sale159.6917,0002,714,68143,606Aug 16 04:06 PM
Saxonov SergeChief Executive OfficerAug 03Option Exercise9.2415,000138,660919,068Aug 04 04:48 PM
Saxonov SergeChief Executive OfficerAug 03Sale178.0315,0002,670,471904,068Aug 04 04:48 PM
Hindson Benjamin J.See RemarksAug 02Option Exercise4.0241,666167,31989,120Aug 04 04:45 PM
McAnear Justin J.Chief Financial OfficerAug 02Option Exercise5.0410,00050,40049,370Aug 04 04:46 PM
Hindson Benjamin J.See RemarksAug 02Sale180.3541,6667,514,46647,454Aug 04 04:45 PM
STUELPNAGEL JOHN RDirectorAug 02Sale180.425,000902,102386,616Aug 04 04:47 PM
McAnear Justin J.Chief Financial OfficerAug 02Sale180.3810,0001,803,82139,370Aug 04 04:46 PM
Kosaraju SridharDirectorJul 23Sale183.671,500275,50010,500Jul 26 04:35 PM
STUELPNAGEL JOHN RDirectorJul 16Sale170.315,000851,529391,616Jul 20 04:08 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJul 12Option Exercise1.1617,00019,72060,606Jul 14 04:42 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJul 12Sale186.5317,0003,170,99643,606Jul 14 04:42 PM
Saxonov SergeChief Executive OfficerJul 06Option Exercise9.2415,000138,660919,068Jul 08 04:24 PM
Saxonov SergeChief Executive OfficerJul 06Sale193.0815,0002,896,138904,068Jul 08 04:24 PM
Hindson Benjamin J.See RemarksJul 01Option Exercise1.2041,66649,99989,120Jul 06 04:28 PM
McAnear Justin J.Chief Financial OfficerJul 01Option Exercise5.0410,00050,40049,370Jul 06 04:29 PM
STUELPNAGEL JOHN RDirectorJul 01Sale191.645,000958,215396,616Jul 06 04:30 PM
McAnear Justin J.Chief Financial OfficerJul 01Sale191.5610,0001,915,63339,370Jul 06 04:29 PM
Hindson Benjamin J.See RemarksJul 01Sale191.5341,6667,980,30147,454Jul 06 04:28 PM
Kosaraju SridharDirectorJun 23Sale199.951,500299,92312,000Jun 25 04:23 PM
STUELPNAGEL JOHN RDirectorJun 17Sale199.385,000996,921401,616Jun 21 05:07 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJun 14Option Exercise1.1617,00019,72060,262Jun 16 06:03 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJun 14Sale191.6917,0003,258,73643,262Jun 16 06:03 PM
Saxonov SergeChief Executive OfficerJun 08Option Exercise9.2415,000138,654919,068Jun 10 04:25 PM
Saxonov SergeChief Executive OfficerJun 08Sale186.3715,0002,795,588904,068Jun 10 04:25 PM
McAnear Justin J.Chief Financial OfficerJun 01Option Exercise5.0410,00050,40049,011Jun 03 06:51 PM
Hindson Benjamin J.See RemarksJun 01Option Exercise1.2041,66649,99989,120Jun 03 06:49 PM
STUELPNAGEL JOHN RDirectorJun 01Sale174.497,5001,308,665405,991Jun 03 06:51 PM
Hindson Benjamin J.See RemarksJun 01Sale174.4141,6667,267,00347,454Jun 03 06:49 PM
McAnear Justin J.Chief Financial OfficerJun 01Sale174.4110,0001,744,06939,011Jun 03 06:51 PM
Saxonov SergeChief Executive OfficerMay 24Sale162.66771125,411904,268May 26 08:27 PM
Kosaraju SridharDirectorMay 24Sale161.161,500241,74613,500May 26 08:28 PM
McAnear Justin J.Chief Financial OfficerMay 24Sale162.6628145,70739,011May 26 08:26 PM
Hindson Benjamin J.See RemarksMay 24Sale162.6635157,09447,454May 26 08:25 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMay 24Sale162.6628145,70743,262May 26 08:25 PM
STUELPNAGEL JOHN RDirectorMay 17Sale141.577,5001,061,740413,491May 19 06:18 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMay 12Option Exercise1.1617,00019,72051,608May 13 07:33 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMay 12Sale134.7817,0002,291,22134,608May 13 07:33 PM
Saxonov SergeChief Executive OfficerMay 04Option Exercise9.2415,000138,660895,468May 05 05:15 PM
Saxonov SergeChief Executive OfficerMay 04Sale184.0815,0002,761,127880,468May 05 05:15 PM
Hindson Benjamin J.See RemarksMay 03Option Exercise1.1241,66646,86978,302May 05 05:10 PM
McAnear Justin J.Chief Financial OfficerMay 03Option Exercise5.0410,00050,40040,357May 05 05:13 PM
STUELPNAGEL JOHN RDirectorMay 03Sale191.817,5001,438,551420,991May 05 05:14 PM
McAnear Justin J.Chief Financial OfficerMay 03Sale191.9310,0001,919,31130,357May 05 05:13 PM
Hindson Benjamin J.See RemarksMay 03Sale191.8441,6667,993,00736,636May 05 05:10 PM
Kosaraju SridharDirectorApr 23Sale193.081,500289,62315,000Apr 27 05:58 PM
STUELPNAGEL JOHN RDirectorApr 16Sale192.617,5001,444,543428,491Apr 19 05:02 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerApr 12Option Exercise1.1617,00019,72051,608Apr 13 04:40 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerApr 12Sale185.8917,0003,160,05334,608Apr 13 04:40 PM
Saxonov SergeChief Executive OfficerApr 06Option Exercise9.2415,000138,660895,468Apr 08 04:34 PM
Saxonov SergeChief Executive OfficerApr 06Sale195.8115,0002,937,143880,468Apr 08 04:34 PM
Hindson Benjamin J.See RemarksApr 01Option Exercise1.0741,66644,58378,302Apr 02 05:19 PM
McAnear Justin J.Chief Financial OfficerApr 01Option Exercise5.0410,00050,40040,357Apr 02 05:21 PM
STUELPNAGEL JOHN RDirectorApr 01Sale184.537,5001,383,969435,991Apr 02 05:22 PM
McAnear Justin J.Chief Financial OfficerApr 01Sale184.5210,0001,845,21230,357Apr 02 05:21 PM
Hindson Benjamin J.See RemarksApr 01Sale184.5441,6667,689,00836,636Apr 02 05:19 PM
Kosaraju SridharDirectorMar 23Sale174.631,500261,93916,500Mar 25 08:32 PM
STUELPNAGEL JOHN RDirectorMar 17Sale169.367,5001,270,181443,491Mar 18 09:09 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMar 12Option Exercise1.1617,00019,72051,608Mar 16 04:51 PM
Hindson Benjamin J.See RemarksMar 12Option Exercise0.9041,66637,67378,302Mar 16 04:52 PM
Saxonov SergeChief Executive OfficerMar 12Option Exercise9.2415,000138,654895,468Mar 16 04:53 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerMar 12Sale157.0117,0002,669,21834,608Mar 16 04:51 PM
Hindson Benjamin J.See RemarksMar 12Sale156.9841,6666,540,90536,636Mar 16 04:52 PM
Saxonov SergeChief Executive OfficerMar 12Sale157.0415,0002,355,569880,468Mar 16 04:53 PM
McAnear Justin J.Chief Financial OfficerMar 10Option Exercise11.489,583110,01330,357Mar 10 07:24 PM
McAnear Justin J.Chief Financial OfficerMar 08Option Exercise5.0410,00050,40030,774Mar 10 07:24 PM
McAnear Justin J.Chief Financial OfficerMar 08Sale147.3010,0001,472,95420,774Mar 10 07:24 PM
STUELPNAGEL JOHN RDirectorMar 01Sale183.187,5001,373,887450,991Mar 03 05:06 PM
STUELPNAGEL JOHN RDirectorFeb 16Sale193.007,5001,447,516458,491Feb 18 05:58 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerFeb 01Option Exercise1.1617,00019,72051,608Feb 03 08:06 PM
McAnear Justin J.Chief Financial OfficerFeb 01Option Exercise5.0410,00050,40030,774Feb 03 08:08 PM
Saxonov SergeChief Executive OfficerFeb 01Option Exercise5.6110,00056,144890,468Feb 03 08:09 PM
STUELPNAGEL JOHN RDirectorFeb 01Sale176.057,5001,320,380465,991Feb 03 08:10 PM
Hindson Benjamin J.See RemarksFeb 01Sale175.9833,7505,939,45636,636Feb 03 08:08 PM
McAnear Justin J.Chief Financial OfficerFeb 01Sale176.0510,0001,760,47920,774Feb 03 08:08 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerFeb 01Sale175.9917,0002,991,76534,608Feb 03 08:06 PM
Saxonov SergeChief Executive OfficerFeb 01Sale176.0010,0001,760,043880,468Feb 03 08:09 PM
STUELPNAGEL JOHN RDirectorJan 19Sale178.767,5001,340,699473,491Jan 21 04:28 PM
CRUTCHFIELD BRADFORDChief Commercial OfficerJan 04Option Exercise1.1617,00019,72051,608Jan 06 05:12 PM
McAnear Justin J.Chief Financial OfficerJan 04Option Exercise5.0410,00050,40030,774Jan 06 05:13 PM
Saxonov SergeChief Executive OfficerJan 04Option Exercise5.0410,00050,400890,468Jan 06 05:14 PM
Saxonov SergeChief Executive OfficerJan 04Sale139.9310,0001,399,262880,468Jan 06 05:14 PM